Dr. Lal Pathlabs Ltd. Financials: Quarterly Results
Revenue
684.2
Cr.
PAT
91.40
Cr.
EBITDA
161.60
Cr.
Dr. Lal Pathlabs Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 659.80 | 730.60 | 669.80 | 602.60 | 596.70 |
| Total Income From Operations (Cr.) | 659.80 | 730.60 | 669.80 | 602.60 | 596.70 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 161.60 | 208.40 | 185.80 | 158.40 | 143.60 |
| P/L Before Exceptional Items & Tax (Cr.) | 154.40 | 203.60 | 181.10 | 153.40 | 138.30 |
| P/L After Tax from Ordinary Activities (Cr.) | 91.40 | 152.20 | 134 | 155.50 | 98.10 |
| Net Profit/Loss For the Period (Cr.) | 91.40 | 152.20 | 134 | 155.50 | 98.10 |
| Basic EPS | 5.42 | 18.05 | 15.88 | 18.57 | 11.60 |
FAQs
Dr. Lal Pathlabs Ltd. announced its quarterly results for Q3 FY2026 on January 30, 2026.
In Q3 FY2026, Dr. Lal Pathlabs Ltd. are as follows:
Revenue: ₹684.2 crore
Net Profit: ₹91.40 crore.
For Q3 FY2026, Dr. Lal Pathlabs Ltd. posted ₹684.2 crore in revenue and ₹91.40 crore in net profit.
Past quarterly results for Dr. Lal Pathlabs Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.